BioWorld

Jan. 8, 2004

View Archived Issues

PTC To Fund Drug Development Through $35M Financing Round

PTC Therapeutics Inc. raised $35 million to support its initial clinical drug development activities and other product research. (BioWorld Today) Read More

Elan's Former Neurex Product, Prialt, Hits Phase III Endpoint

Read More

New Drug Efalizumab OK'd By FDA But Not As Definitive Cure; Psoriasis Still Plagues Legions

Read More

Thios Adds To Pipeline Through TS1 Licensing Deal With Wyeth

Read More

Forbes Medi-Tech Private Placement Raises $10.75M

Read More

Other News To Note

Read More